Efficacy of neuromuscular electrical stimulation for thoracic and abdominal surgery: A systematic review and meta-analysis.
Yuki NakashimaDaisuke IwakiYuki KataokaTakashi AriieShunsuke TaitoYuichi NishikawaNaoki MioYukio MikamiPublished in: PloS one (2023)
This systematic review and meta-analysis examined the efficacy of neuromuscular electrical stimulation (NMES) on lower limb muscle strength and health-related quality of life (HR-QOL) after thoracic and abdominal surgery. We searched the Cochrane Central Register of Controlled Trials, MEDLINE via PubMed, Excerpta Medica Database via Elsevier, Physiotherapy Evidence Database, Cumulative Index to Nursing and Allied Health Literature, World Health Organization International Clinical Trials Registry Platform via their dedicated search portal, and ClinicalTrials.gov on November 2021 and updated in April 2023 to identify randomized controlled trials that examined the effects of NMES after thoracic and abdominal surgery. The primary outcomes were lower limb muscle strength, HR-QOL, and adverse events. We used the Cochrane Risk of Bias Tool and the Grading of Recommendations, Assessment, Development, and Evaluation approach to assess the certainty of evidence. A total of 18 randomized control trials involving 915 participants, including 10 on cardiovascular surgery, two on pulmonary surgery, five on digestive system surgery, and one on other surgery, were included. NMES slightly increased lower limb muscle strength and adverse events in cardiovascular surgery. Adverse events (hypotension, pain, and muscle discomfort) occurred in seven patients. HR-QOL was measured in two studies on cardiovascular surgery, but these were not pooled due to concept heterogeneity. Overall, NMES slightly increases lower limb muscle strength after cardiovascular surgery without serious adverse events. However, higher-quality randomized control trials in thoracic and abdominal surgeries are needed.
Keyphrases
- lower limb
- minimally invasive
- coronary artery bypass
- clinical trial
- surgical site infection
- randomized controlled trial
- end stage renal disease
- systematic review
- public health
- chronic kidney disease
- mental health
- spinal cord injury
- type diabetes
- open label
- quality improvement
- double blind
- climate change
- high throughput
- ejection fraction
- peritoneal dialysis
- phase iii
- skeletal muscle
- single cell
- placebo controlled
- insulin resistance
- atrial fibrillation